Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1999
08/11/1999EP0934083A1 Improved vaccines
08/11/1999EP0934081A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/11/1999EP0934077A2 Polyanionic polymers as adjuvants for mucosal immunization
08/11/1999EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/11/1999EP0759032B1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
08/11/1999EP0755403B1 Method of separating protective components of bordetella pertussis
08/11/1999EP0741744B1 Immunogens against gonadotropin releasing hormone
08/11/1999EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
08/11/1999EP0651609B1 Pasteurella multocida toxoid vaccines
08/11/1999EP0580778B1 Convertible microemulsion formulations
08/11/1999CN1225685A Avian polynucleotide vaccine formula for anti birds' disease
08/11/1999CN1225684A Avian polynucleotide vaccine formula for anti pig's diseases
08/11/1999CN1225683A Vasoactive amine binding molecules
08/11/1999CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity
08/11/1999CN1225590A Peptides with increased binding affinity for HLA molecules
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/10/1999US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935865 Semaphorin gene family
08/10/1999US5935821 Nucleotide sequence that codes polypeptide anti-idiotype immunoglobulin a ganglioside useful in the suppression of cancer and reduction of recurrence; anticarcinogenic agents
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935812 Polynucleotide
08/10/1999US5935798 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/10/1999US5935601 Acylated peptide as a carrier for oral administration
08/10/1999US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin
08/10/1999US5935583 A vaccine strain of giardia which is cultured in media containing bile so as to produce a toxin in vitro for preventing or treating intestinal protozoal infections in an animal
08/10/1999US5935580 Recombinant adenylate cyclase of bordetella comprising at least one heterologous insert, such as an epitope at a permissive site within the n-terminal portion of the adneylate cyclase; and which exhibits invasive activity
08/10/1999US5935579 A peptide will stimulate proliferation of a t-cell clone in a t-cell proliferation assay and produce an alloepitopic effect, peptide when administered in a tolerizing amount will suppress proliferation of t-cell clone in second assay
08/10/1999US5935578 Contraceptive vaccine
08/10/1999US5935577 Treatment of autoimmune disease using tolerization in combination with methotrexate
08/10/1999US5935576 Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
08/10/1999US5935575 Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders
08/10/1999US5935573 Hybrid protein
08/10/1999US5935569 Genetic anticancer vaccine
08/10/1999US5935568 Gene therapy for effector cell regulation
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999CA2126863C Chimeric immunogens
08/10/1999CA2093434C Regulation of immunoglobulin production by interleukin-9
08/10/1999CA2069611C Method to detect bone and other connective tissue disorders in humans and animals
08/10/1999CA1340703C Production of insulin-like growth factor binding protein
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038978A1 Methods and reagents for decreasing allergic reactions
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038954A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/05/1999WO1999038953A1 Development of regulatory cells as a means for treating autoimmune disease
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038887A1 Divergent hiv-1 peptides
08/05/1999WO1999038880A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038531A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
08/05/1999WO1999038530A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
08/05/1999WO1999038529A1 Vaccine composition comprising milled lyophilisate of antigenic whole cells
08/05/1999WO1999038528A2 Vaccine formulations
08/05/1999WO1999038525A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999WO1999038520A1 Blood cell composition as a vaccine for hiv and other pathogenic organisms
08/05/1999WO1999038383A1 Method for producing extract of olive leaves and extract produced thereby
08/05/1999WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
08/05/1999WO1999025367A3 Treatment of hematologic disorders
08/05/1999WO1999024472A3 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/05/1999WO1999022766A3 Use of anti-il-12 antibodies in transplantation rejection
08/05/1999WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999019357A3 Cell regulatory genes, encoded products, and uses related thereto
08/05/1999WO1999018210A3 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
08/05/1999WO1999018206A3 Human cancer antigen ny eso-1/cag-3 and gene encoding same
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999WO1998036778A8 Sustained drug delivery and compositions useful therefor
08/05/1999WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2319711A1 Vaccine
08/05/1999CA2319698A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999CA2319666A1 Development of regulatory cells as a means for treating autoimmune disease
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999CA2318190A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
08/04/1999EP0933426A1 Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932684A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
08/04/1999EP0932683A1 Attenuated microorganism strains expressing hpv proteins
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932613A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
08/04/1999EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
08/04/1999EP0932415A1 Method of preventing acute rejection following solid organ transplantation
08/04/1999EP0932411A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
08/04/1999EP0932392A1 Method for inducing a systemic immune response to an antigen
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0585242B1 Wound healing
08/04/1999EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene
08/04/1999EP0538437B1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
08/04/1999CN1225132A HIV envelope polypeptides and vaccine
08/04/1999CN1224621A Rotavirus resisting immune globulin composite and its preparation and use
1 ... 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 ... 1823